Fasinumab Terminated Phase 2 Trials for Back pain Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01001715Single Injection of REGN475/SAR164877 in Treatment of Vertebral Fracture Pain